Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
100.00%
Operating Margin
49.77%
Net Margin
481.65%
Efficiency Metrics
Revenue per Expense Ratio
1.99
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
481.63%
Income Tax Rate
0.00%
EPS
2.7200000000
Balance Sheet Analysis
Current Ratio
10.41
Cash Ratio
0.64
Working Capital
$4.53M
Debt to Equity
0.06
Debt to Assets
5.47%
Equity Ratio
94.40%
Cash Flow Analysis
Operating Cash Flow Ratio
21.18%
Free Cash Flow Ratio
21.18%
CapEx to Revenue
0.00%
Dividends Paid
$127.10M
Stock Buybacks
$3.72M
Total Shareholder Returns
$130.83M
Cash Position Change
861.56%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
114.60%
Net Income
169.94%
EPS
165.38%
Operating Income
107.27%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
1,237.00%
Operating Cash Flow
-42.91%
Free Cash Flow
-42.91%
Balance Sheet Health
Assets
4.77%
Debt
0.00%
Book Value per Share
11.52%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
-1.39%
Shares Outstanding
3.36%
Long Term Trends
3Y Revenue/Share
-73.77%
5Y Revenue/Share
121.47%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%